Topics
Gliomas | Diagnosis | Liquid biopsy
Home > Publications > Topics > Gliomas > Diagnosis > Liquid biopsy
Distinguishing True Progression From Pseudoprogression
*Li K, Zhu Q, Yang J, Zheng Y, Du S, Song M, Peng Q, Yang R, Liu
Y, Qi L.
Imaging and Liquid Biopsy for
Distinguishing True Progression From Pseudoprogression in Gliomas,
Current Advances and Challenges.
Acad Radiol. 2024 Apr
12:S1076-6332(24)00162-4. doi:
10.1016/j.acra.2024.03.019. PMID:
38614827. Review. ˍ
CSF Biomarkers
Mikolajewicz N, Yee PP, Bhanja D, Trifoi M, Miller AM, Metellus P,
Bagley SJ, Balaj L, de Macedo Filho LJM, Zacharia BE, Aregawi D,
Glantz M, Weller M, Ahluwalia MS, Kislinger T, Mansouri
A.
Systematic Review of Cerebrospinal
Fluid Biomarker Discovery in Neuro-Oncology: A Roadmap to
Standardization and Clinical Application.
J
Clin Oncol. 2024 Apr 12:JCO2301621. doi:
10.1200/JCO.23.01621. PMID:
38608213. Review˰ ˍ
Distinguishing True Progression From Pseudoprogression
*Li K, Zhu Q, Yang J, Zheng Y, Du S, Song M, Peng Q, Yang R, Liu
Y, Qi L.
Imaging and Liquid Biopsy for
Distinguishing True Progression From Pseudoprogression in Gliomas,
Current Advances and Challenges.
Acad Radiol. 2024 Apr
12:S1076-6332(24)00162-4. doi:
10.1016/j.acra.2024.03.019. PMID:
38614827. Review. ˍ
Inflammatory Markers
Huang T, Sun F, Gao K, Wang Y, Zhu G, Chen F.
The
role of Peripheral Inflammatory Markers and Coagulation factors in
patients with CNS immune disease and glioma.
World
Neurosurg. 2024 May 17:S1878-8750(24)00843-X. doi:
10.1016/j.wneu.2024.05.080. PMID:
38763458. Observational study˰
ˍ
CSF Biomarkers
Papadimitrakis D, Perdikakis M, Gargalionis AN, Papavassiliou AG.
Biomarkers in Cerebrospinal Fluid for
the Diagnosis and Monitoring of Gliomas.
Biomolecules.
2024 Jul 5;14(7):801. doi:
10.3390/biom14070801. PMID:
39062515. Review. ˍ
Inflammatory Markers
Li B, Gao B, Zhu HJ, Luwor RB, Lu J, Zhang L, Kong B.
The
Prognostic Value of Preoperative Inflammatory Markers for
Pathological Grading of Glioma Patients.
Technol
Cancer Res Treat. 2024 Aug 5;23:15330338241273160. doi:
10.1177/15330338241273160. PMID:
39099463. Observational study. ˍ
IDH1.R132H-mutant
Batool SM, Escobedo AK, Hsia T, Ekanayake E, Khanna SK, Gamblin
AS, Zheng H, Skog J, Miller JJ, Stemmer-Rachamimov AO, Cahill DP,
Balaj L, Carter BS.
Clinical utility of
a blood based assay for the detection of IDH1.R132H-mutant
gliomas.
Nat
Commun. 2024 Aug 16;15(1):7074. doi:
10.1038/s41467-024-51332-7. PMID:
39152110. Observational
study. ˍ
Circulating biomarkers
Detchou D, Barrie U.
Circulating
biomarkers literature in glioma patient populations.
Neurosurg
Rev. 2024 Aug 27;47(1):484. doi:
10.1007/s10143-024-02738-w. PMID:
39187709. Review˰ ˍ
Metabolic markers
**Löding S, Antti H, Sjöberg RL, Melin B, Björkblom
B.
Blood based metabolic markers of
glioma from pre-diagnosis to surgery.
Sci
Rep. 2024 Sep 5;14(1):20680. doi:
10.1038/s41598-024-71375-6. PMID:
39237693. Observational study. ˍ
White blood cells
Zhou J, Tan B, Gao F.
Prognostic
values of combined ratios of white blood cells in glioma: a
systematic review and meta-analysis.
Neurosurg
Rev. 2024 Oct 31;47(1):831. doi:
10.1007/s10143-024-03064-x. PMID:
39477886. Review; Meta-analysis˰
ˍ
Circulating Tumor DNA
Lu Y, Wang Z, Zhang D, Luo N, Yang H, Chen D, Huang H.
Application of Circulating Tumor DNA
in the Auxiliary Diagnosis and Prognosis Prediction of Glioma.
Cell
Mol Neurobiol. 2024 Dec 18;45(1):6. doi:
10.1007/s10571-024-01515-z. PMID:
39692767. Review. ˍ
CSF Biomarkers
Riviere-Cazaux C, Keough MB, Zuccato JA, Kumar R, Schulz S,
Warrington AE, Ruff MW, Ellingson BM, Sanai N, Campian JL,
Kizilbash SH, Parney IF, Zadeh G, Khasraw M, Kessler T, Sener U,
Cahill DP, Mansouri A, Burns TC.
A
Hitchhiker's Guide Toward CSF Biomarkers for Neuro-Oncology.
Neuro
Oncol. 2024 Dec 30:noae276. doi:
10.1093/neuonc/noae276. PMID:
39786477. Review. ˍ
H3F3A K27M or BRAF V600E
Madlener S, Stepien N, Senfter D, Mayr L, Laemmerer A, Hedrich C,
Baumgartner A, Lötsch-Gojo D, Sterba J, Pokorna P, Kiesel B,
Widhalm G, Eckert F, Preusser M, Rössler K, Azizi A, Peyrl A,
Czech T, Haberler C, Slavc I, Kasprian G, Dorfer C, Furtner J,
Gojo J.
Detection of H3F3A K27M or
BRAF V600E in liquid biopsies of
brain tumor patients as diagnostic and monitoring biomarker:
impact of tumor localization
and sampling method.
Acta
Neuropathol. 2025 Jan 3;149(1):5. doi:
10.1007/s00401-024-02842-7. PMID:
39751690. Observational study. ˍ